You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site

Continue

Go back

SHINGRIX safety profile

Median follow-up period of 4.4 years (0–5.0 years) 1

References:

  1. SHINGRIX Product Monograph. GlaxoSmithKline Inc., October 13, 2017.